These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29721181)

  • 1. Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Knapp DW; Karagiannis SN; Fazekas-Singer J; Choyke PL; LeBlanc AK; Jensen-Jarolim E; Kobayashi H
    Oncotarget; 2018 Apr; 9(27):19026-19038. PubMed ID: 29721181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near infrared photoimmunotherapy of B-cell lymphoma.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
    Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Gastric Cancer; 2019 May; 22(3):463-472. PubMed ID: 30171392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
    Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
    Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
    Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
    Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
    Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Cancer Sci; 2018 Jun; 109(6):1902-1908. PubMed ID: 29676827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
    Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.